Funders › CA › Arthritis National Research Foundation › 2019
Grants paid by Arthritis National Research Foundation, tax year 2019
EIN 95-6043953 · Irvine, CA · Form 990, Schedule I · NTEE H41Z
In tax year 2019, Arthritis National Research Foundation (EIN 95-6043953) reported 16 grants paid totaling $1,600,000. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2019
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2019 | Northwestern University Evanston, IL | A | $100,000 | paid | COMPARING THE REGULATORY NETWORKS UNDERLYING INFLAMMATION IN ARTHRITIS & AGING. | 202020239349301222 |
| 2019 | Van Andel Research Institute Grand Rapids, MI | A | $100,000 | paid | THE FUNCTION OF SENP6 DESUMOYLASE IN PREVENTING ARTICULAR CHONDROCYTE SENESCENCE AND OSTEOARTHRITIS DEVELOPMENT (2ND YEAR). | 202020239349301222 |
| 2019 | Uc San Francisco Pediatrics Los Angeles, CA | A | $100,000 | paid | CHARACTERIZATION OF A NOVEL EPICGENETIC REGULATOR OF TH17 DIFFERENTIATION. | 202020239349301222 |
| 2019 | University of Michigan Pittsburgh, PA | A | $100,000 | paid | THE ROLE OF MATRICELLULAR PROTEIN CYR61 IN FIBROSIS AND ANGIOGENESIS IN SCLERODERMA. | 202020239349301222 |
| 2019 | University of Alabama at Birmingham Birmingham, AL | A | $100,000 | paid | INFLUENCE OF THE SURROGATE LIGHT CHAIN PROTEIN ON BONE HEALTH AND ARTHRITIS IN AGING. | 202020239349301222 |
| 2019 | Rush University Medical Center Chicago, IL | A | $100,000 | paid | IDENTIFYING NOVEL MECHANOTRANSDUCTION TARGETS FOR TREATING OSTEOARTHRITIS. | 202020239349301222 |
| 2019 | University of North Carolina Atlanta, GA | A | $100,000 | paid | TARGETING SENESCENT CELLS TO LIMIT CARTILAGE DEGRADATION AND OSTEOARTHRITIS. | 202020239349301222 |
| 2019 | Baylor College of Medicine Dallas, TX | A | $100,000 | paid | VALIDATING STAT3 AS A THERAPEUTIC TARGET IN ARTHRITIS. | 202020239349301222 |
| 2019 | Rush University Medical Center Chicago, IL | A | $100,000 | paid | ROLE OF IL36A IN OSTEOARTHRITIS PROGRESSION. | 202020239349301222 |
| 2019 | University of Oklahoma Health Sciences Center Oklahoma City, OK | A | $100,000 | paid | EPIGENETICS AT THE INTERSECTION OF TRAUMA, AGING, AND OSTEOARTHRITIS. | 202020239349301222 |
| 2019 | Brigham and Women's Hospital Boston, MA | A | $100,000 | paid | MEGAKARYOCYTES AS NEUTROPHIL AMPLIFIERS IN INFLAMMATORY ARTHRITIS. | 202020239349301222 |
| 2019 | Brigham and Women's Hospital Boston, MA | A | $100,000 | paid | CHARACTERIZATION OF A CD8 T CELL SUBSET ENRICHED IN BLOOD OF PATIENTS WITH RHEUMATOID ARTHRITIS. | 202020239349301222 |
| 2019 | The Feinstein Institute for Medical Research Philadelphia, PA | A | $100,000 | paid | THE ROLE OF TNF AND TNFR1 IN BREAKING B CELL TOLERANCE. | 202020239349301222 |
| 2019 | University of Washington Chicago, IL | A | $100,000 | paid | TARGETING PLATELET-DERIVED GROWTH FACTOR RECEPTOR- (PDGFR) IN RHEUMATOID ARTHRITIS. | 202020239349301222 |
| 2019 | University of Michigan Ann Arbor, MI | A | $100,000 | paid | GENETIC REPROGRAMMING OF OA CHONDROCYTES TO IMPROVE CARTILAGE REPAIR. | 202020239349301222 |
| 2019 | Uc San Francisco Los Angeles, CA | A | $100,000 | paid | DECODING RHEUMATOID ARTHRITIS USING A UNIQUE TOOL TO IDENTIFY ARTHRITOGENIC T CELLS. | 202020239349301222 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.